HLA-DRB1*15 was strongly protective in the total diabetes group (7/188, 3.7%) compared with control participants (25/152, 16.4%; OR 0.20; p < 0.0001); this association persisted when GADA-positive cases only were considered (2/102, 2.0%). This evidence concerns the gene HLA-DRB1 and diabetes mellitus.